Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Deleu

Showing results (51-60 of 112) with videos related to

Pageof 12
Sort By:
Epilepsy Research|January 14, 2021
Complementary and alternative medicine (CAM) for epilepsy treatment in the Middle East and North Africa (MENA) regionBoulenouar Mesraoua, Najib Kissani, Dirk Deleu, et al.
Current Medical Research and Opinion|May 10, 2014
Multicenter cross-sectional study of asymptomatic peripheral arterial disease among patients with a single previous coronary or cerebrovascular event in the Arabian GulfAmit Kumar, Marzouk Al-Bader, Hassan Al-Thani, et al.
Seizure|December 24, 2002
Patient's perspective on epilepsy: self-knowledge among OmanisSamir Al-Adawi, Hamoud Al-Salmy, Roger G Martin, et al.
Idcases|January 26, 2022
Complicated Neurotuberculosis with sinus venous thrombosis: A case-reportYousra Ali, Yahia Imam, Hasan S Ahmedullah, et al.
Current Medical Research and Opinion|November 29, 2016
Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from QatarDirk Deleu, Boulenouar Mesraoua, Hisham El Khider, et al.
Current Medical Research and Opinion|May 17, 2018
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overviewDirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, et al.
European Stroke Journal|April 23, 2019
Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registryNaveed Akhtar, Abdul Salam, Saadat Kamran, et al.
Neurology and Therapy|June 22, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Neurology and Therapy|June 17, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
The International Journal of Neuroscience|February 19, 2011
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle EastDirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, et al.
Pageof 12

Showing results (51-60 of 112) with videos related to

Sort By:
Pageof 12
Epilepsy Research|January 14, 2021
Complementary and alternative medicine (CAM) for epilepsy treatment in the Middle East and North Africa (MENA) regionBoulenouar Mesraoua, Najib Kissani, Dirk Deleu, et al.
Current Medical Research and Opinion|May 10, 2014
Multicenter cross-sectional study of asymptomatic peripheral arterial disease among patients with a single previous coronary or cerebrovascular event in the Arabian GulfAmit Kumar, Marzouk Al-Bader, Hassan Al-Thani, et al.
Seizure|December 24, 2002
Patient's perspective on epilepsy: self-knowledge among OmanisSamir Al-Adawi, Hamoud Al-Salmy, Roger G Martin, et al.
Idcases|January 26, 2022
Complicated Neurotuberculosis with sinus venous thrombosis: A case-reportYousra Ali, Yahia Imam, Hasan S Ahmedullah, et al.
Current Medical Research and Opinion|November 29, 2016
Optimization and stratification of multiple sclerosis treatment in fast developing economic countries: a perspective from QatarDirk Deleu, Boulenouar Mesraoua, Hisham El Khider, et al.
Current Medical Research and Opinion|May 17, 2018
Oral disease-modifying therapies for multiple sclerosis in the Middle Eastern and North African (MENA) region: an overviewDirk Deleu, Boulenouar Mesraoua, Beatriz Canibaño, et al.
European Stroke Journal|April 23, 2019
Ethnic variation in acute cerebrovascular disease: Analysis from the Qatar stroke registryNaveed Akhtar, Abdul Salam, Saadat Kamran, et al.
Neurology and Therapy|June 22, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Neurology and Therapy|June 17, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
The International Journal of Neuroscience|February 19, 2011
Will new injection devices for interferon β-1a s.c. affect treatment adherence in patients with multiple sclerosis? An expert opinion in the Middle EastDirk Deleu, Issa Alsharoqi, Mohammed Ali Al Jumah, et al.
Pageof 12